Skip to main content
. 2021 Jun 7;13(1):1930636. doi: 10.1080/19420862.2021.1930636

Table 3.

In silico prediction of the immunogenicity of antibodies

Antibody Immunogenicity score
Pembrolizumab 35
Ab2001.10 63
Omalizumab 76
Sintilimab 79
Ab2001.08 (JMB2002) 85
Trastuzumab 92
Nivolumab 105
Imdevimab (REGN10987) 113
Dacetuzumab 150
Adalimumab 160
Roledumab 173
CB6 174
Lorvotuzumab 213